These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1479739)

  • 1. A stable metabolite, Arg-Pro-Pro-Gly-Phe, of bradykinin in the degradation pathway in human plasma.
    Shima C; Majima M; Katori M
    Jpn J Pharmacol; 1992 Oct; 60(2):111-9. PubMed ID: 1479739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in the kinin levels in the bronchial washings after intravenous injection of leukotriene C4 in guinea pigs.
    Majima M; Jin HY; Katori M; Sunahara N
    Agents Actions Suppl; 1992; 38 ( Pt 3)():467-74. PubMed ID: 1462880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of bradykinin agonists and antagonists by plasma aminopeptidase P.
    Ward PE; Chow A; Drapeau G
    Biochem Pharmacol; 1991 Jul; 42(4):721-7. PubMed ID: 1651078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of brain endopeptidases: influence of size and sequence of substrates structurally related to bradykinin.
    Oliveira EB; Martins AR; Camargo AC
    Biochemistry; 1976 May; 15(9):1967-74. PubMed ID: 5120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the digestion of bradykinin, Lys-bradykinin, and des-Arg9-bradykinin by angiotensin converting enzyme.
    Sheikh IA; Kaplan AP
    Biochem Pharmacol; 1986 Jun; 35(12):1951-6. PubMed ID: 3013204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of des-Arg9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation.
    Raymond P; Drapeau G; Raut R; Audet R; Marceau F; Ong H; Adam A
    J Immunol Methods; 1995 Mar; 180(2):247-57. PubMed ID: 7714339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bradykinin B1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis.
    Butt SK; Dawson LG; Hall JM
    Br J Pharmacol; 1995 Feb; 114(3):612-7. PubMed ID: 7735687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of bradykinin and its metabolites by rat brain synaptic membranes.
    Orawski AT; Simmons WH
    Peptides; 1989; 10(5):1063-73. PubMed ID: 2608554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of the degradation products of bradykinin by enzyme immunoassays as markers for the release of kinin in vivo.
    Majima M; Sunahara N; Harada Y; Katori M
    Biochem Pharmacol; 1993 Feb; 45(3):559-67. PubMed ID: 8442755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinin metabolism in the perfused ventilated rat lung. I: Bradykinin metabolism in a system modeling the normal, uninjured lung.
    Baker CR; Little AD; Little GH; Canizaro PC; Behal FJ
    Circ Shock; 1991 Jan; 33(1):37-47. PubMed ID: 2009602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
    Vianna RM; Calixto JB
    Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema.
    Blais C; Rouleau JL; Brown NJ; Lepage Y; Spence D; Munoz C; Friborg J; Geadah D; Gervais N; Adam A
    Immunopharmacology; 1999 Sep; 43(2-3):293-302. PubMed ID: 10596866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum interspecies differences in metabolic pathways of bradykinin and [des-Arg9]BK: influence of enalaprilat.
    Décarie A; Raymond P; Gervais N; Couture R; Adam A
    Am J Physiol; 1996 Oct; 271(4 Pt 2):H1340-7. PubMed ID: 8897926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma.
    Cyr M; Lepage Y; Blais C; Gervais N; Cugno M; Rouleau JL; Adam A
    Am J Physiol Heart Circ Physiol; 2001 Jul; 281(1):H275-83. PubMed ID: 11406494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of endogenous Des-Arg9-[Hyp3]-bradykinin in human plasma with post-source-decay matrix-assisted laser desorption/ionization mass spectrometry.
    Schlüter H; Mentrup D; Gross I; Meyer HE; Spengler B; Kaufmann R; Zidek W
    Anal Biochem; 1997 Mar; 246(1):15-9. PubMed ID: 9056177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of Sar-[D-Phe8]des-Arg9-bradykinin, a metabolically protected agonist of B1 receptor for kinins, in the anesthetized rabbit pretreated with a sublethal dose of bacterial lipopolysaccharide.
    Audet R; Rioux F; Drapeau G; Marceau F
    J Pharmacol Exp Ther; 1997 Jan; 280(1):6-15. PubMed ID: 8996175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypotensive effects of Lys-des-Arg9-bradykinin and metabolically protected agonists of B1 receptors for kinins.
    Drapeau G; deBlois D; Marceau F
    J Pharmacol Exp Ther; 1991 Dec; 259(3):997-1003. PubMed ID: 1662280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A useful and sensitive method for demonstration of the involvement of either kallikrein-kinin system in pathological states.
    Majima M; Sunahara N; Uchida Y; Katori M
    Agents Actions Suppl; 1992; 38 ( Pt 1)():441-8. PubMed ID: 1466291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of des arginine9-bradykinin and other bradykinin fragments on the synthesis of prostacyclin and the binding of bradykinin by vascular cells in culture.
    Cahill M; Fishman JB; Polgar P
    Agents Actions; 1988 Jul; 24(3-4):224-31. PubMed ID: 3051930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B1 and B2 kinin receptors on cultured rabbit superior mesenteric artery smooth muscle cells: receptor-specific stimulation of inositol phosphate formation and arachidonic acid release by des-Arg9-bradykinin and bradykinin.
    Tropea MM; Gummelt D; Herzig MS; Leeb-Lundberg LM
    J Pharmacol Exp Ther; 1993 Feb; 264(2):930-7. PubMed ID: 8382284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.